$795.67
-0.61-0.08%
At close: -
$792.46
-3.21-0.40%
After Hours: 4:46 PM EDT
Comments
Loading...
Latest news for Eli Lilly (NYSE:LLY) Stock
Eli Lilly Stock (NYSE: LLY)
Categories: All
Monday, December 23, 2024
Sunday, December 22, 2024
Friday, December 20, 2024
- FDA Approves Eli Lilly's Zepbound For Moderat...
- EXCLUSIVE: Weight-Loss Market Experts Scoop Up Novo Nordisk Stock After Worst Drop Since 2002 Following Drug Trial Miss
- Benzinga Market Summary: Novo Nordisk Falls O...
- Lilly shares are trading higher in reaction t...
- Novo Nordisk's Hybrid Weight Loss Drug Falls Short On Expectations, Stock Plunges
Thursday, December 19, 2024
Wednesday, December 18, 2024
Tuesday, December 17, 2024
Monday, December 16, 2024
Friday, December 13, 2024
Thursday, December 12, 2024
Wednesday, December 11, 2024
Tuesday, December 10, 2024
- Eli Lilly's $15 Billion Buyback Faces Stiff Resistance On The Charts
- Lilly CEO Says To Test Obesity Drugs For Smok...
- What's Going On With Eli Lilly Stock On Tuesday?
- Market-Moving news for December 10th
- B of A Securities Reinstates Buy on Eli Lilly...
- As Eli Lilly Shares Gain Over 35% YTD, Drugmaker Announces $15B Share Buyback Program And Boosts Dividend By 15%
Monday, December 09, 2024
- Eli Lilly Reports Results From Phase 3 BRUIN ...
- Eli Lilly Increases Quarterly Dividend From $...
- Eli Lilly shares are trading higher after the...
- Eli Lilly Announced A New $1.5B Share Repurch...
- Biogen Downgraded On Pipeline Setbacks And Leqembi Sales Slowdown
- Just Two Months After IPO, BioAge Labs Stops Eli Lilly-Collaborated Obesity Trial On Safety Concerns